A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms

Matrix metalloproteinase 9 (MMP‐9) has recently emerged as a molecule that contributes to pathological synaptic plasticity in schizophrenia, but explanation of the underlying mechanisms has been missing. In the present study, we performed a phenotype‐based genetic association study (PGAS) in > 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepeta, Katarzyna, Purzycka, Katarzyna J, Pachulska‐Wieczorek, Katarzyna, Mitjans, Marina, Begemann, Martin, Vafadari, Behnam, Bijata, Krystian, Adamiak, Ryszard W, Ehrenreich, Hannelore, Dziembowska, Magdalena, Kaczmarek, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538295/
https://www.ncbi.nlm.nih.gov/pubmed/28623238
http://dx.doi.org/10.15252/emmm.201707723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538295/
https://www.ncbi.nlm.nih.gov/pubmed/28623238
http://dx.doi.org/10.15252/emmm.201707723

Ejemplares similares